Respiratory failure & ventilation

Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial

Anaesth Crit Care Pain MedPublished Secondary analysis of the ICAR randomised trial

Authors' conclusion

Inflammatory subphenotypes were stable in COVID-19-related ARDS, with few transitions over 28 days.

Study context

Population
Patients with COVID-19-related moderate-to-severe acute respiratory distress syndrome (ARDS), 43 centres
Participants
146 patients · 43 centres
Comparison
Hyperinflammatory vs hypoinflammatory ARDS subphenotype
  • Hyperinflammatoryn = 25
  • Hypoinflammatoryn = 121reference
Primary endpoint
Temporal stability of ARDS subphenotypes (transitions over 7-day intervals)
Follow-up
28 days
Methodological detailsmulticentre, K-means clustering, Bayesian discrete-time Markov model
  • Multicentre
  • K-means clustering
  • Bayesian discrete-time Markov model

Primary result

As reported in the abstract

Transition probabilities over 7-day intervals (Bayesian Markov model)

Extubated

OutcomeHypoinflammatoryHyperinflammatory
Remaining hypoinflammatory70%— not stated in the abstract
Progressing to hyperinflammatory7%— not stated in the abstract
Remaining hyperinflammatory— not stated in the abstract52%
Dying— not stated in the abstract23%
Transitioning to hypoinflammatory— not stated in the abstract20%

— not stated in the abstract

Further findings

28-day mortality

P = 0.001

OutcomeP value
Ventilator-free days through day 28Fewer in hyperinflammatoryP < 0.01

Organ failure, plasma biomarkers, endothelial stability

Hyperinflammatory: higher organ failure rates, higher cytokines, chemokines, adhesion molecules and proangiogenic factors, lower endothelial stability vs hypoinflammatory

Original publication

Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial. Anaesth Crit Care Pain Med. Published 26 May 2025. doi:10.1016/j.accpm.2025.101559

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.